Our next article is live on the Bioentrepreneur website. Titled In vogue with venture, it was written by Gary Patou, managing director at MPM Capital. (You can find his bio page here.)
His piece details what MPM finds attractive today, and explains why. He also provides some insight into companies MPM has invested in recently, and discusses the reasoning for turning down an opportunity with a type 2 diabetes drug. You can read it here; for the PDF, go here.